Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Prolapse | 2 | 2017 | 82 | 0.230 |
Why?
|
| Surgical Mesh | 2 | 2017 | 126 | 0.220 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2023 | 198 | 0.180 |
Why?
|
| Urinary Incontinence | 1 | 2023 | 216 | 0.180 |
Why?
|
| Cost of Illness | 1 | 2021 | 155 | 0.170 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2021 | 91 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 276 | 0.150 |
Why?
|
| Ligaments | 1 | 2017 | 34 | 0.140 |
Why?
|
| Suture Techniques | 1 | 2017 | 144 | 0.130 |
Why?
|
| Zygote | 2 | 2006 | 41 | 0.120 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 275 | 0.110 |
Why?
|
| Quality of Life | 2 | 2021 | 1744 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2011 | 523 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 293 | 0.080 |
Why?
|
| Swine | 2 | 2006 | 605 | 0.070 |
Why?
|
| Oocytes | 2 | 2006 | 221 | 0.070 |
Why?
|
| Blastocyst | 1 | 2006 | 35 | 0.070 |
Why?
|
| Fluorides, Topical | 1 | 2006 | 1 | 0.060 |
Why?
|
| Cathepsin D | 1 | 2006 | 5 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2006 | 60 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 119 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2006 | 82 | 0.060 |
Why?
|
| Vault Ribonucleoprotein Particles | 1 | 2005 | 1 | 0.060 |
Why?
|
| Saliva | 1 | 2006 | 126 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2006 | 379 | 0.050 |
Why?
|
| Dysuria | 1 | 2023 | 8 | 0.050 |
Why?
|
| Mammals | 1 | 2005 | 245 | 0.050 |
Why?
|
| Menopause | 1 | 2023 | 85 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2023 | 93 | 0.050 |
Why?
|
| Estrogens | 1 | 2023 | 200 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2006 | 374 | 0.050 |
Why?
|
| Perception | 1 | 2021 | 183 | 0.040 |
Why?
|
| Patient Preference | 1 | 2021 | 120 | 0.040 |
Why?
|
| Health Expenditures | 1 | 2021 | 97 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 1771 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2021 | 325 | 0.040 |
Why?
|
| Female | 6 | 2023 | 47893 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2006 | 1576 | 0.040 |
Why?
|
| Sacrococcygeal Region | 1 | 2017 | 9 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2017 | 360 | 0.030 |
Why?
|
| Illinois | 1 | 2017 | 503 | 0.030 |
Why?
|
| Decision Making | 1 | 2021 | 680 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 19943 | 0.030 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2017 | 159 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2006 | 323 | 0.030 |
Why?
|
| Humans | 8 | 2023 | 92337 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2006 | 795 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2011 | 39 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6916 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 431 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2012 | 283 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 569 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 828 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 8740 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 27030 | 0.020 |
Why?
|
| Animals | 4 | 2011 | 28003 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 680 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 797 | 0.020 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2006 | 8 | 0.020 |
Why?
|
| Cloning, Organism | 1 | 2006 | 19 | 0.020 |
Why?
|
| Centrosome | 1 | 2006 | 22 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2006 | 63 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2006 | 90 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 2035 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1310 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2005 | 28 | 0.010 |
Why?
|
| Oogenesis | 1 | 2005 | 47 | 0.010 |
Why?
|
| Fertilization in Vitro | 1 | 2005 | 58 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 2669 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 441 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1720 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 268 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 79 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 501 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 2498 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 891 | 0.010 |
Why?
|
| Mice | 2 | 2011 | 12110 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 200 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 9703 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 2074 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2902 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 2317 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 2037 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 3017 | 0.010 |
Why?
|
| Male | 2 | 2011 | 43925 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 27532 | 0.010 |
Why?
|